147 related articles for article (PubMed ID: 13224672)
21. The factor VIII complex: structure and function.
Hoyer LW
Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681
[TBL] [Abstract][Full Text] [Related]
22. Inactive factor VIII in hemophilia A and Willebrand's disease. A study of 117 cases.
Lechner K
Acta Haematol; 1972; 48(5):257-68. PubMed ID: 4629531
[No Abstract] [Full Text] [Related]
23. Assay of antihaemophilic factor using the prothrombin conversion ratio.
WOLF P
Br J Haematol; 1956 Oct; 2(4):386-96. PubMed ID: 13383105
[No Abstract] [Full Text] [Related]
24. Antihemophilic factor (factor VIII).
Ratnoff OD
Ann Intern Med; 1978 Mar; 88(3):403-9. PubMed ID: 343683
[TBL] [Abstract][Full Text] [Related]
25. Occurrence of two hemorrhagic disorders with antihemophilic factor (AHF) deficiency in the same family: classical hemophilia and von willebrand's disease.
GEIGER MT; RATH CE
J Lab Clin Med; 1963 Mar; 61():424-36. PubMed ID: 13947010
[No Abstract] [Full Text] [Related]
26. A circulating anticoagulant selectively active against human antihemophilic factor (autoimmune hemophilia).
SPAET TH; KINSELL BG
Stanford Med Bull; 1954 Nov; 12(4):246-56. PubMed ID: 13225986
[No Abstract] [Full Text] [Related]
27. Hemorrhagic disease with circulating inhibitors of blood clotting: anti-AHF and anti-PTC in eight cases.
ARENDS T; FERGUSON JH; LEWIS JH
Blood; 1956 Sep; 11(9):846-55. PubMed ID: 13355894
[No Abstract] [Full Text] [Related]
28. The mode of action and aetiology of antihaemophilic globulin inhibitors.
BIGGS R; BIDWELL E; MACFARLANE RG
Sang; 1959; 30():340-51. PubMed ID: 13800639
[No Abstract] [Full Text] [Related]
29. [Study of the preservation of the A and B antihemophilic factors in lyophylized plasma].
DUCOS J; BIERME R
Rev Fr Etud Clin Biol; 1959 Dec; 4():1057-9. PubMed ID: 13818417
[No Abstract] [Full Text] [Related]
30. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
31. Factor 8 detection by hemagglutination inhibition: hemophilia A and von Willebrand's disease.
Stites DP; Hershgold EJ; Perlman JD; Fudenberg HH
Science; 1971 Jan; 171(3967):196-7. PubMed ID: 5312959
[TBL] [Abstract][Full Text] [Related]
32. A method for the study of antihaemophilic globulin inhibitors with reference to six cases.
BIGGS R; BIDWELL E
Br J Haematol; 1959 Oct; 5():379-95. PubMed ID: 13800640
[No Abstract] [Full Text] [Related]
33. [Comparative determination of the antihemophilic globulin in both sexes].
FISCHER J; LANDBECK G; LENZ W
Klin Wochenschr; 1958 Jan; 36(1):20-2. PubMed ID: 13540108
[No Abstract] [Full Text] [Related]
34. The influence of hydergine on the coagulation time in hemophilia.
SIMONOVIC I
Acta Haematol; 1955 Aug; 14(2):96-9. PubMed ID: 13258141
[No Abstract] [Full Text] [Related]
35. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
Weiss HJ; Sussman II; Hoyer LW
J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
[TBL] [Abstract][Full Text] [Related]
36. In-vivo study on the relation between Bridge anticoagulant and antihaemophilic globulin.
NOUR-ELDIN F; WILKINSON JF
Br J Haematol; 1958 Jul; 4(3):292-301. PubMed ID: 13572740
[No Abstract] [Full Text] [Related]
37. The effect of clotting on structure and function of human factor VIII.
Gordon NR; Shulman NR
Ann N Y Acad Sci; 1975 Jan; 240():79-83. PubMed ID: 1078623
[No Abstract] [Full Text] [Related]
38. The antihaemophilic-globulin concentration in the plasma of female carriers of haemophilia.
GARDIKAS C; KATSIROUMBAS P; KOTTAS C
Br J Haematol; 1957 Oct; 3(4):377-8. PubMed ID: 13479686
[No Abstract] [Full Text] [Related]
39. Studies on factor VIII activation potential in hemophilia A-plasma and its significance for the comprehension of hemophilia.
Mingers AM
Eur J Pediatr; 1976 Oct; 123(3):187-98. PubMed ID: 1086208
[TBL] [Abstract][Full Text] [Related]
40. On demonstration of the haemophilic conductor, especially by determination of the coagulation time.
SJØLIN KE
Acta Pathol Microbiol Scand; 1954; 35(6):512-22. PubMed ID: 13228064
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
